Nerve transfer surgery gives hope to children with rare paralyzing illness
School of Medicine surgeon Amy Moore, MD, has performed nerve transfer surgeries on children stricken with a rare paralyzing illness called acute flaccid myelitis. Researchers believe the condition may be caused by a common enterovirus.
Less anesthesia during surgery doesn’t prevent post-op delirium
One in four older adults experiences delirium after surgery. However, School of Medicine researchers have found that closely monitoring brain activity and minimizing anesthesia if needed has no significant effect on the occurrence of delirium.
Women’s brains appear three years younger than men’s
A new study from the School of Medicine finds that women’s brains appear to be about three years younger than men’s of the same chronological age, metabolically speaking. The findings could be one clue to why women tend to stay mentally sharp longer than men.
Drug target identified for chemotherapy-resistant ovarian, breast cancer
Researchers at the School of Medicine may have found a path toward improving the effectiveness of chemotherapy in people with breast or ovarian cancer caused by defects in one of the BRCA genes. The researchers identified a pair of genes that operate in parallel to BRCA and may increase susceptibility to chemotherapy drugs.
New clues discovered to lung transplant rejection
Researchers at the School of Medicine have discovered clues to a particularly deadly form of rejection that can follow lung transplantation. Called antibody-mediated rejection, the condition remains impervious to available treatments and difficult to diagnose. The researchers have identified, in mice, a process that may prevent the condition and lead to possible therapies to treat it.
WashU Expert: New Trump drug policy proposal ambitious, but is it feasible?
The Trump Administration released a proposed rule Jan. 31 that could alter the way many drugs are priced and paid for among Medicare and Medicaid plans. The proposed regulation would eliminate the regulatory safe harbor for rebates as they exist today, said Rachel Sachs, an expert on drug policy and pricing at Washington University in St. Louis.
Teitelbaum awarded 2019 King Faisal International Prize in Medicine
The School of Medicine’s Steven Teitelbaum, MD, has been awarded the King Faisal International Prize in Medicine for his work on bone biology. The award recognizes scientists whose work has major benefits for humanity.
Modernizing radiation therapy in Guatemala
With the help of a grant from the U.S. Agency for International Development, an international team that includes scientists from the School of Medicine is poised to improve cancer care in Guatemala with new state-of-the-art radiation therapy equipment.
Brown School faculty part of international obesity report
The Brown School’s Ross Hammond and Peter Hovmand are both part of the Lancet Commission on Obesity, which released its major new report Jan. 27. The main takeaway? Obesity, climate change and hunger are inextricably linked and must be fought as one challenge.
Brown School launches substance use disorder clinic
The Brown School has partnered with Preferred Family Healthcare in St. Louis to launch the Community Academic Partnership on Addiction (CAPA), a teaching, learning and research clinic aimed at addressing substance use disorder. The Brown School’s David Patterson Silver Wolf serves as CAPA’s chief research officer.
Older Stories